| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |